AzTrials
AzTrials

Low Back PainNCT07166900

Modified Thoracolumbar Interfascial Plane Block Versus Erector Spinae Plane Block For Enhancement Of Quality of Recovery After Lumbar Spine Surgery: A Prospective Randomized Controlled Study.

A study testing Modified Thoracolumbar Interfascial Plane Block in people with Low Back Pain, run by Fayoum University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Aim of study The objective of the current study is to compare the efficacy of ultrasound-guided bilateral modified thoracolumbar interfascial plane (TLIP) block versus erector spinae (ES) block in optimizing early quality of recovery (QOR) following lumbar spine surgery under general anesthesia. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Low Back Pain
What is being tested?
Modified Thoracolumbar Interfascial Plane Block
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
64 participants
Where
1 siteEgypt
Study dates
1 Jun 2025to 1 Mar 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient scheduled for elective lumbar spine fixation 2-3 levels.
  • American Society of Anesthesiologists(ASA) class I-III.

Who cannot join

  • 1. Obese patients (Body Mass Index> 35). 2. Patients with neurological deficits, cardiopulmonary disease, hepatic or renal impairment.
  • 3. Patients with history of severe allergies to local anesthetics or other medications used during the procedure.
  • 4. Patients with history of coagulation disorder or anticoagulants. 5. Patients with emergency surgeries or re-do surgeries. 6. Patients with systemic infections or infections at the site of injection. 7. Patients with Psychiatric illnesses. 8. Patients with history of drug addiction

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Fayoum university hospital

    Al Fayyum

Other trials in Egypt

About this study

Aim of study The objective of the current study is to compare the efficacy of ultrasound-guided bilateral modified thoracolumbar interfascial plane (TLIP) block versus erector spinae (ES) block in optimizing early quality of recovery (QOR) following lumbar spine surgery under general anesthesia.

Read the detailed description

Lumbar spine surgery, a common surgical procedure to alleviate spinal stenosis or disc herniation, is often associated with significant postoperative pain that can hinder early recovery and patient satisfaction. Effective pain management is critical to improve the quality of recovery (QOR), reducing complications, and facilitating early mobilization (1). Regional anesthesia techniques, such as nerve blocks, have gained popularity as part of multimodal analgesia strategies to minimize opioid use and enhance postoperative outcomes. Among these, the thoracolumbar interfascial plane (TLIP) block and the erector spinae (ES) block have emerged as promising ultrasound-guided techniques for managing pain after lumbar spine surgeries (2).

Conditions
Low Back Pain
Being tested
Modified Thoracolumbar Interfascial Plane Block
Medical subject headings
Low Back Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Modified Thoracolumbar Interfascial Plane BlockProcedure or surgery

    The TLIP block, introduced as a modification of the lumbar interfascial plane block, targets the dorsal rami of the thoracolumbar nerves by injecting local anesthetic into the fascial plane between the multifidus and longissimus muscles. This technique is designed to provide analgesia to the posterior elements of the spine, which are often the primary sources of pain after laminectomy

Study groups in NCT07166900
Study groupRoleWhat they receive
EspbActive comparatorNot described
Receives: Procedure: Modified Thoracolumbar Interfascial Plane Block
TlibActive comparatorNot described
Receives: Procedure: Modified Thoracolumbar Interfascial Plane Block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quality of Recovery (QOR)

    Assessed using the QOR-15 questionnaire at 24 hours postoperatively

    Measured: 24 hours postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Sep 2025
  2. Study start1 Jun 2025
  3. Primary completion1 Feb 2026
  4. Study completion1 Mar 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
64 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07166900
Sponsor's protocol ID
M800
Status last verified
May 2026
First submitted
9 Sep 2025
Last updated
13 May 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Modified Thoracolumbar Interfascial Plane Block in people with Low Back Pain, run by Fayoum University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quality of Recovery (QOR) (time frame: 24 hours postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in